Comparative Thrombolytic Properties of Tissue-Type Plasminogen Activator and of a Plasminogen Activator Inhibitor-1 -Resistant Glycosylation Variant, in a Combined Arterial and Venous Thrombosis Model in the Dog
Désiré Collen
1
The Center for Molecular and Vascular Biology, University of Leuven, Belgium
,
Jean-Marie Stassen
1
The Center for Molecular and Vascular Biology, University of Leuven, Belgium
,
Tsunehiro Yasuda
2
Division of Cardiology, Massachusetts General Hospital Harvard Medical School, Boston, MA, USA
,
Canio Refino
3
Department of Cardiovascular Pharmacology, Genentech Inc, South San Francisco, CA, USA
,
Nicholas Paoni
3
Department of Cardiovascular Pharmacology, Genentech Inc, South San Francisco, CA, USA
,
Bruce Keyt
3
Department of Cardiovascular Pharmacology, Genentech Inc, South San Francisco, CA, USA
,
Tania Roskams
4
Department of Pathology, University of Leuven, Belgium
,
J Luis Guerrero
2
Division of Cardiology, Massachusetts General Hospital Harvard Medical School, Boston, MA, USA
,
Henri R Lijnen
1
The Center for Molecular and Vascular Biology, University of Leuven, Belgium
,
Herman K Gold
2
Division of Cardiology, Massachusetts General Hospital Harvard Medical School, Boston, MA, USA
,
William F Bennett
3
Department of Cardiovascular Pharmacology, Genentech Inc, South San Francisco, CA, USA